1. Academic Validation
  2. Antiviral enantiomeric preference for 5'-noraristeromycin

Antiviral enantiomeric preference for 5'-noraristeromycin

  • J Med Chem. 1994 Feb 18;37(4):551-4. doi: 10.1021/jm00030a014.
S M Siddiqi 1 X Chen S W Schneller S Ikeda R Snoeck G Andrei J Balzarini E De Clercq
Affiliations

Affiliation

  • 1 Department of Chemistry, University of South Florida, Tampa 33620-5250.
Abstract

In order to determine if the potent Antiviral properties of (+/-)-5'-noraristeromycin reside in one of its enantiomers, an analysis of each enantiomer has been carried out. A five-step route to the (+)-stereoisomer is described from (+)-(1R,4S)-4-hydroxy-2-cyclopenten-1-yl acetate, whereas the synthesis of the (-)-enantiomer had been reported previously from the same starting material. The (-)-2 and (+)-2 enantiomers were evaluated for Antiviral activity against a large number of viruses and found to display an Antiviral activity spectrum characteristic of (S)-adenosyl-L-homocysteine hydrolase inhibitors. The (-)-enantiomer retained the significant anticytomegalovirus properties previously reported for the racemic 2 and was, on the average, 10-fold more potent than (+)-2 in inhibiting virus replication, tumor cell growth, and (S)-adenosyl-L-homocysteine hydrolase activity.

Figures